Moderna: good news on skin cancer vaccine is welcome distraction from Covid-19 shot sales woes
US biotech company’s stock worth nearly $500 at its peak in August 2021, currently trades at less than $87
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Cancer Vaccines | Covid Vaccine | COVID-19 | Pharmaceuticals | Skin | Skin Cancer | Vaccines